Constitution Medical, Inc.
Constitution Medical, Inc. (CMI) is a Massachusetts-based developer of innovative laboratory products whose goal is to deliver revolutionary new technologies. CMI is a subsidiary of Constitution Medical Investors, Inc. The senior management team of CMI brings with them a wealth of experience in the development of innovative new technologies. CMI is primarily funded by Warburg Pincus.
Warburg Pincus has been a leading private equity investor since 1971. The firm currently has more than $35 billion of asset under management. Warburg Pincus’ investments are focused on a range of sectors in North America, Europe and Asia, including financial services, healthcare, industrial, technology, media and telecommunications, energy, consumer and retail, and real estate. Since inception, the firm has raised 12 private equity funds that have invested more than $61 billion in approximately 600 companies in more than 30 countries. The firm has invested $6.6 billion in healthcare-related companies around the world, including approximately $1.6 billion to help build nearly 40 biotechnology and pharmaceutical companies. The firm has an active global portfolio of more than 125 companies and offices in Beijing, Frankfurt, Hong Kong, London, Mumbai, New York, San Francisco, Shanghai and Tokyo. For more information, visit www.warburgpincus.com.